Antimicrobial Peptide Wound Dressings That Kill Bacteria and Help Wounds Heal

A protease-resistant antimicrobial peptide embedded in nanocellulose wound dressings successfully cleared wound infections in a pig model while promoting healing and showing low toxicity to human skin cells.

Zattarin, Elisa et al.·Materials today. Bio·2025·
RPEP-144572025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

In a porcine (pig) wound infection model, the antimicrobial peptide PLNC8 αβ eradicated wound infections and promoted re-epithelialization (new skin growth over the wound).

Two types of nanocellulose dressings were tested: bacterial cellulose (BC) and wood-derived TEMPO-oxidized nanocellulose (TC). Both showed effective contact killing of bacteria on the dressing surface but were less effective against bacteria floating in wound fluid.

The breakthrough came from incorporating mesoporous silica nanoparticles (MSNs) into the dressings as peptide carriers. MSN-functionalized dressings achieved significantly higher peptide loading and sustained release, resulting in improved antimicrobial efficacy against both surface and suspended bacteria. All formulations showed low cytotoxicity toward human fibroblasts and keratinocytes.

Key Numbers

How They Did This

Researchers developed two types of nanocellulose wound dressings (bacterial cellulose and TEMPO-oxidized wood nanocellulose) loaded with the antimicrobial peptide PLNC8 αβ. The peptide was either adsorbed directly onto nanocellulose fibers or encapsulated in mesoporous silica nanoparticles (MSNs) embedded in the dressings. They tested antimicrobial activity against bacteria, cytotoxicity against human primary fibroblasts and keratinocytes, and efficacy in a porcine (pig) wound infection model measuring both bacterial clearance and wound healing (re-epithelialization).

Why This Research Matters

Antibiotic-resistant wound infections are a growing crisis — chronic non-healing wounds affect millions of patients and cost healthcare systems billions annually. Antimicrobial peptides are promising alternatives to antibiotics because bacteria have difficulty developing resistance to them. By embedding a protease-resistant peptide in a wound dressing that slowly releases it, this approach could provide sustained infection control without repeated applications, directly addressing one of the biggest challenges in wound care.

The Bigger Picture

This study sits at the intersection of antimicrobial peptide research, nanotechnology, and wound care — three rapidly advancing fields. The use of mesoporous silica nanoparticles as peptide carriers within a biocompatible wound dressing represents a sophisticated delivery strategy that could be adapted for other therapeutic peptides. As antibiotic resistance continues to escalate, peptide-based wound treatments may become essential clinical tools, and this work demonstrates a practical path from peptide discovery to a functional medical device.

What This Study Doesn't Tell Us

While the pig wound model is more clinically relevant than mouse models, the study has not been tested in human patients. Specific quantitative data (exact bacterial counts, peptide release rates, healing times) are not provided in the abstract. The study used a single bacterial species or limited range of pathogens — real wound infections often involve mixed bacterial communities. Long-term stability and shelf-life of the functionalized dressings were not addressed.

Questions This Raises

  • ?How would PLNC8 αβ-loaded nanocellulose dressings perform against polymicrobial wound infections with multiple resistant bacterial species?
  • ?What is the shelf life and storage stability of these peptide-functionalized dressings for real-world clinical use?
  • ?Could this mesoporous silica nanoparticle delivery approach be adapted to deliver other therapeutic peptides (e.g., growth factors) to accelerate wound healing further?

Trust & Context

Key Stat:
Infection eradicated PLNC8 αβ eliminated wound infection in a pig model while simultaneously promoting re-epithelialization — addressing both infection and healing
Evidence Grade:
This is a preclinical study combining in vitro cell studies with an in vivo porcine wound model. Pig wound models are considered among the best animal models for human wound healing, which strengthens the translational relevance. However, no human data exists yet for this specific formulation.
Study Age:
Published in 2025, this is a very recent study representing the current state of antimicrobial peptide delivery research. The nanocellulose-MSN delivery platform is a novel approach that has not yet been clinically tested.
Original Title:
Controlled release of antimicrobial peptides from nanocellulose wound dressings for treatment of wound infections.
Published In:
Materials today. Bio, 32, 101756 (2025)
Database ID:
RPEP-14457

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why use antimicrobial peptides instead of antibiotics in wound dressings?

Bacteria are increasingly resistant to conventional antibiotics, making wound infections harder to treat. Antimicrobial peptides kill bacteria through mechanisms that make it very difficult for bacteria to develop resistance — they typically disrupt bacterial cell membranes directly rather than targeting a single molecular pathway that bacteria can mutate around.

What makes PLNC8 αβ special compared to other antimicrobial peptides?

One of the biggest challenges with antimicrobial peptides is that enzymes in wounds (proteases) break them down before they can work. PLNC8 αβ is protease-resistant, meaning it stays active in the harsh wound environment. Combined with the slow-release nanoparticle delivery system, it can provide sustained antimicrobial activity rather than a brief burst.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-14457·https://rethinkpeptides.com/research/RPEP-14457

APA

Zattarin, Elisa; Sotra, Zeljana; Wiman, Emanuel; Bas, Yagmur; Rakar, Jonathan; Berglund, Linn; Starkenberg, Annika; Björk, Emma M; Khalaf, Hazem; Oksman, Kristiina; Bengtsson, Torbjörn; Junker, Johan P E; Aili, Daniel. (2025). Controlled release of antimicrobial peptides from nanocellulose wound dressings for treatment of wound infections.. Materials today. Bio, 32, 101756. https://doi.org/10.1016/j.mtbio.2025.101756

MLA

Zattarin, Elisa, et al. "Controlled release of antimicrobial peptides from nanocellulose wound dressings for treatment of wound infections.." Materials today. Bio, 2025. https://doi.org/10.1016/j.mtbio.2025.101756

RethinkPeptides

RethinkPeptides Research Database. "Controlled release of antimicrobial peptides from nanocellul..." RPEP-14457. Retrieved from https://rethinkpeptides.com/research/zattarin-2025-controlled-release-of-antimicrobial

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.